These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7946177)

  • 1. Sustained-release isradipine compared with spirapril in the treatment of elderly patients with isolated systolic hypertension.
    Tomlinson B; Woo J; Critchley JA; Or KK; Chan TY; Sanderson JE
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):35S-39S. PubMed ID: 7946177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.
    Abarquez RF; Sy RG; Castillo RR
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):77S-79S. PubMed ID: 8466734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
    Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B
    Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
    Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
    Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isradipine in the treatment of mild-to-moderate hypertension. The Austrian Multicenter Isradipine cum Spirapril Study (AMICUS).
    Magometschnigg D
    Am J Hypertens; 1993 Mar; 6(3 Pt 2):49S-53S. PubMed ID: 8466726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.
    Guitard C; Lohmann FW; Alfiero R; Ruina M; Alvisi V
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossover comparison of atenolol, enalapril, hydrochlorothiazide and isradipine for isolated systolic systemic hypertension.
    Silagy CA; McNeil JJ; McGrath BP
    Am J Cardiol; 1992 Nov; 70(15):1299-305. PubMed ID: 1442581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
    Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
    Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACE inhibition with spirapril improves diastolic function at rest independent of vasodilation during treatment with spirapril in mild to moderate hypertension.
    Petersen JR; Drabaek H; Gleerup G; Mehlsen J; Petersen LJ; Winther K
    Angiology; 1996 Mar; 47(3):233-40. PubMed ID: 8638865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter comparison of adverse reaction profiles of isradipine and enalapril at equipotent doses in patients with essential hypertension.
    Johnson BF; Eisner GM; McMahon FG; Jain AK; Rudd P; Sowers JR
    J Clin Pharmacol; 1995 May; 35(5):484-92. PubMed ID: 7657848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
    Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
    Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of atenolol, enalapril, and isradipine in elderly hypertensive women.
    Perry HM; Hall WD; Benz JR; Bartels DW; Kostis JB; Townsend RR; Due DL; Peng A; Sirgo M
    Am J Med; 1994 Jan; 96(1):77-86. PubMed ID: 8304366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of isradipine and spirapril on left ventricular hypertrophy and resistance arteries.
    Thürmann PA; Stephens N; Heagerty AM; Kenedi P; Weidinger G; Rietbrock N
    Hypertension; 1996 Sep; 28(3):450-6. PubMed ID: 8794832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
    Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
    Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisinopril dose-response relationship in essential hypertension.
    Gomez HJ; Cirillo VJ; Sromovsky JA; Otterbein ES; Shaw WC; Rush JE; Chrysant SG; Gradman AH; Leon AS; MacCarthy EP
    Br J Clin Pharmacol; 1989 Oct; 28(4):415-20. PubMed ID: 2556172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained blood pressure control with controlled-release isradipine (isradipine-CR).
    Chrysant SG; Cohen M
    J Clin Pharmacol; 1995 Mar; 35(3):239-43. PubMed ID: 7608311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C; Sassano P; Tzincoca C; Duchiez J; Safar ME
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
    Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
    Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.